In this issue of The CMTA Report, we highlight pivotal moments and inspiring stories within the CMT community. The spotlight shines on new initiatives and advancements, including announcing the UK’s new CMTA Center of Excellence at St. George’s University Hospitals, enhancing patient care and support.
We explore how artificial intelligence revolutionizes CMT diagnosis, treatment, and management with a dedicated feature by CMTA Chief Research Officer Katherine Forsey, PhD, on page 20 in her column, Under the Microscope. Additionally, community stories emphasize health, fitness, and innovative coping strategies for living with CMT. From adaptive exercises to daily living tips, members share their personal journeys and practical advice.
The research section brings exciting updates, including the rapid progression of the CMT-SORD clinical trials and groundbreaking work in gene editing and biobanking. A particular focus is on repurposing drugs for CMT1A and developing nanoparticles for gene therapy in various types of CMT.
Join us in welcoming Chris Cosentino, our new Director of Marketing, who aims to amplify CMTA’s mission and engagement. The COMPASS program continues to support young adults, fostering community and connection.
Read the full stories and more in the Summer 2024 CMTA Report.